Business · 20/02/2026Updated: 10/16/2026 · 1 min read
FDA Announces Public Comment Period for Proposed Collection of Adverse Event Reporting Information
The FDA is seeking public comment on a proposed collection of information related to adverse event reporting by the agency on new animal drugs and product manufacturing defects, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →